{
    "organizations": [],
    "uuid": "c6099e82ef3f22ab6cb88704f26359eb0a6cbbd6",
    "author": "",
    "url": "https://www.reuters.com/article/brief-psivida-granted-waiver-by-the-fda/brief-psivida-granted-waiver-by-the-fda-for-new-drug-application-filing-fee-idUSASB0BZPW",
    "ord_in_thread": 0,
    "title": "BRIEF-Psivida Granted Waiver By The FDA For New Drug Application Filing Fee",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 4, 2018 / 12:24 PM / in 9 minutes BRIEF-Psivida Granted Waiver By The FDA For New Drug Application Filing Fee Reuters Staff \nJan 4 (Reuters) - Psivida Corp: \n* PSIVIDA GRANTED WAIVER BY THE FDA FOR NEW DRUG APPLICATION FILING FEE \n* PSIVIDA CORP - ON TRACK TO FILE DURASERT NDA IN EARLY JANUARY \n* PSIVIDA - FDA GRANTED BUSINESS WAIVER OF PDUFA FEE OF ABOUT $2.4 MILLION FOR NDA FOR COâ€˜S DURASERT 3 YEAR MICROINSERT FOR POSTERIOR SEGMENT UVEITIS Source text for Eikon: Further company coverage:",
    "published": "2018-01-04T14:23:00.000+02:00",
    "crawled": "2018-01-04T14:36:09.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "granted",
        "waiver",
        "fda",
        "new",
        "drug",
        "application",
        "filing",
        "fee",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "psivida",
        "corp",
        "psivida",
        "granted",
        "waiver",
        "fda",
        "new",
        "drug",
        "application",
        "filing",
        "fee",
        "psivida",
        "corp",
        "track",
        "file",
        "durasert",
        "nda",
        "early",
        "january",
        "psivida",
        "fda",
        "granted",
        "business",
        "waiver",
        "pdufa",
        "fee",
        "million",
        "nda",
        "co",
        "durasert",
        "year",
        "microinsert",
        "posterior",
        "segment",
        "uveitis",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}